ドライアイ症候群市場：医薬品、製品別-2025～2030年の世界予測

ドライアイ症候群市場は、2023年に43億9,000万米ドルと評価され、2024年には47億1,000万米ドルに達すると予測され、CAGR 7.21％で成長し、2030年には71億6,000万米ドルに達すると予測されています。

ドライアイ症候群（DES）は、涙の量または質の欠乏を特徴とする多因子疾患であり、炎症と眼表面の損傷を引き起こします。ドライアイ症候群市場には、診断アプローチ、医薬品、機器、代替療法が含まれ、症状の緩和と患者の生活の質の向上を目指しています。人口の高齢化、ライフスタイルの変化、長時間のデジタル画面への露出などにより、世界の有病率の増加に伴い、効果的な管理オプションの必要性がますます高まっています。最終用途は、人工涙液や配合薬から、穿刺プラグや処置用ソリューションのような医療機器まで多岐にわたり、消費者と臨床の両方の環境に対応しています。主要成長要因としては、目の健康に対する一般市民の意識の高まり、診断技術の進歩、新規治療に対する薬事承認の急増などが挙げられます。最新のビジネス機会は、遠隔診断とケアのための遠隔医療の活用、個別化医療アプローチの開拓、未診断人口を抱える新興国市場の拡大にあります。これらをうまく活用するには、研究開発への投資、革新的な提供メカニズムのためのハイテク企業との協力、より幅広いアクセスのための戦略的な価格設定モデルが必要となります。市場は潜在的な可能性を秘めているもの、厳しい規制要件、多額の研究コスト、新規治療に伴う副作用管理などの課題に直面しています。さらに、先進国における市場の飽和や患者のコンプライアンス違反も大きな障害となっています。イノベーションを求める企業にとって、非侵襲的診断ツールの探求、AI主導の患者管理システム、アイケア製品のサステイナブル生産は、有利な展望を記載しています。これらのセグメントは、収益源だけでなく、患者のエンゲージメントとアウトカムの向上も約束します。全体として、市場は医療の進歩と消費者の期待の両方によって非常にダイナミックに動いており、開発戦略には敏捷性と先見性が求められます。利害関係者は、この急成長する健康問題に効果的に対処するため、技術の進歩、規制の進化、消費者の嗜好の変化に遅れをとらないようにしなければならないです。

市場力学：急速に進化するドライアイ症候群市場の主要市場洞察を公開

ドライアイ症候群市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ドライアイ疾患の有病率の増加
  • ドライアイの診断と治療に対する意識の高まり
  • 世界の高齢者の増加
• 市場抑制要因
  • 厳しい規制プロセス
• 市場機会
  • 新規技術の開発
  • 研究開発投資の増加
• 市場課題
  • 製品リコールの増加

ポーターのファイブフォース：ドライアイ症候群市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ドライアイ症候群市場における外部からの影響の把握

外部マクロ環境要因は、ドライアイ症候群市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ドライアイ症候群市場における競合情勢の把握

ドライアイ症候群市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ドライアイ症候群市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ドライアイ症候群市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ドライアイ症候群市場における成功への道筋を描く

ドライアイ症候群市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品上市、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ドライアイ疾患の増加
    • 病気の診断と治療に関する意識の高まり
    • 世界中で高齢化が進む
  • 抑制要因
    • 厳格な規制プロセス
  • 機会
    • 新しい技術の開発
    • 研究開発投資の増加
  • 課題
    • 製品リコールの増加
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ドライアイ症候群市場：医薬品別

• イントロダクション
• 抗炎症薬
• 自己血清点眼薬
• 潤滑点眼薬

第7章 ドライアイ症候群市場：製品別

• イントロダクション
• 眼軟膏
• ゲル
• 液滴
• 液体ワイプ

第8章 南北アメリカのドライアイ症候群市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のドライアイ症候群市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのドライアイ症候群市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• AFT Pharmaceuticals
• Akorn Operating Company LLC
• Alcon Vision LLC
• Bausch & Lomb Pvt Ltd.
• GlaxoSmithKline PLC
• Johnson & Johnson Services, Inc.
• Mitotech S.A.
• Nicox S.A.
• Novartis AG
• Otsuka Holdings Co
• Prestige Consumer Healthcare
• Santen Pharmaceutical Co.ltd
• Sentiss Pharma Pvt. Ltd
• Sun Pharmaceutical Industries Ltd

LIST OF FIGURES

• FIGURE 1. DRY EYE SYNDROME MARKET RESEARCH PROCESS
• FIGURE 2. DRY EYE SYNDROME MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRY EYE SYNDROME MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRY EYE SYNDROME MARKET DYNAMICS
• TABLE 7. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY AUTOLOGOUS SERUM EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LUBRICANT EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY EYE OINTMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRY EYE SYNDROME MARKET SIZE, BY LIQUID WIPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. CANADA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 24. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CHINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 36. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 38. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. ITALY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 73. ITALY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. POLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 81. POLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. QATAR DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 83. QATAR DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2023

The Dry Eye Syndrome Market was valued at USD 4.39 billion in 2023, expected to reach USD 4.71 billion in 2024, and is projected to grow at a CAGR of 7.21%, to USD 7.16 billion by 2030.

Dry Eye Syndrome (DES) is a multifactorial disease characterized by a deficiency in the quantity or quality of tears, leading to inflammation and damage to the ocular surface. The market for Dry Eye Syndrome encompasses diagnostic approaches, pharmaceuticals, devices, and alternative therapies aimed at alleviating symptoms and improving the quality of life for patients. With an increasing global prevalence, driven largely by ageing populations, lifestyle changes, and prolonged digital screen exposure, the necessity for effective management options grows ever more critical. Primary applications and end-uses range from artificial tears and prescription medications to medical devices like punctal plugs and procedural solutions, catering to both consumer and clinical settings. Key growth factors include rising public awareness about eye health, advancements in diagnostic technologies, and a surge in regulatory approvals for novel treatments. The latest opportunities lie in leveraging telehealth for remote diagnosis and care, developing personalized medicine approaches, and expanding markets in emerging regions with underdiagnosed populations. Successfully capitalizing on these requires investments in R&D, collaboration with tech companies for innovative delivery mechanisms, and strategic pricing models for broader access. Despite its potential, the market faces challenges, such as stringent regulatory requirements, substantial research costs, and side effect management associated with new treatments. Additionally, market saturation in developed countries and patient non-compliance pose significant obstacles. For businesses seeking innovation, exploring non-invasive diagnostic tools, AI-driven patient management systems, and sustainable production of eye-care products offer lucrative prospects. These areas promise not just revenue streams but also enhanced patient engagement and outcomes. Overall, the market is highly dynamic, driven by both medical advancements and consumer expectations, necessitating agility and foresight in development strategies. To thrive, stakeholders must stay abreast of technological progress, evolving regulations, and shifting consumer preferences to effectively address this burgeoning health concern.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dry Eye Syndrome Market

The Dry Eye Syndrome Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of dry eye diseases
  • Growing awareness regarding diagnosis and treatment of the disease
  • Rising geriatric population across the world
• Market Restraints
  • Stringent regulatory process
• Market Opportunities
  • Development of novel technologies
  • Increase in R&D investment
• Market Challenges
  • Increase in product recall

Porter's Five Forces: A Strategic Tool for Navigating the Dry Eye Syndrome Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dry Eye Syndrome Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dry Eye Syndrome Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dry Eye Syndrome Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dry Eye Syndrome Market

A detailed market share analysis in the Dry Eye Syndrome Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dry Eye Syndrome Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dry Eye Syndrome Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dry Eye Syndrome Market

A strategic analysis of the Dry Eye Syndrome Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dry Eye Syndrome Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AFT Pharmaceuticals, Akorn Operating Company LLC, Alcon Vision LLC, Bausch & Lomb Pvt Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Mitotech S.A., Nicox S.A., Novartis AG, Otsuka Holdings Co, Prestige Consumer Healthcare, Santen Pharmaceutical Co.ltd, Sentiss Pharma Pvt. Ltd, and Sun Pharmaceutical Industries Ltd.

Market Segmentation & Coverage

This research report categorizes the Dry Eye Syndrome Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug, market is studied across Anti-inflammatory Drugs, Autologous Serum Eye Drops, and Lubricant Eye Drops.
• Based on Product, market is studied across Eye Ointment, Gel, Liquid Drops, and Liquid Wipes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of dry eye diseases
    • 5.1.1.2. Growing awareness regarding diagnosis and treatment of the disease
    • 5.1.1.3. Rising geriatric population across the world
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory process
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of novel technologies
    • 5.1.3.2. Increase in R&D investment
  • 5.1.4. Challenges
    • 5.1.4.1. Increase in product recall
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Dry Eye Syndrome Market, by Drug

• 6.1. Introduction
• 6.2. Anti-inflammatory Drugs
• 6.3. Autologous Serum Eye Drops
• 6.4. Lubricant Eye Drops

7. Dry Eye Syndrome Market, by Product

• 7.1. Introduction
• 7.2. Eye Ointment
• 7.3. Gel
• 7.4. Liquid Drops
• 7.5. Liquid Wipes

8. Americas Dry Eye Syndrome Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Dry Eye Syndrome Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Dry Eye Syndrome Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. AFT Pharmaceuticals
• 3. Akorn Operating Company LLC
• 4. Alcon Vision LLC
• 5. Bausch & Lomb Pvt Ltd.
• 6. GlaxoSmithKline PLC
• 7. Johnson & Johnson Services, Inc.
• 8. Mitotech S.A.
• 9. Nicox S.A.
• 10. Novartis AG
• 11. Otsuka Holdings Co
• 12. Prestige Consumer Healthcare
• 13. Santen Pharmaceutical Co.ltd
• 14. Sentiss Pharma Pvt. Ltd
• 15. Sun Pharmaceutical Industries Ltd